Bicara Therapeutics Inc. Common Stock (BCAX) Analyst Forecast

$11.50

$0.47 (4.26%)
Last update: 04:00 PM EST
Day's range
$10.37
Day's range
$11.84

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
05/23/2025 Wells Fargo Eva Fortea Verdejo $8.00 $9.27   -13.7%
10/08/2024 Morgan Stanley Judah Frommer $35.00 $24.45   43.15%

Bicara Therapeutics Inc. Common Stock FAQ's

Bicara Therapeutics Inc. Common Stock has been rated by research analysts at Wells Fargo, Stifel Nicolaus, Morgan Stanley in the past 90 days.